Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00811031
What this trial is testing

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05720130
What this trial is testing

Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
AdvanCell Pty Limited 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07795268
What this trial is testing

Study to Evaluate the Efficacy and Safety of 177Lu-NYM032 Injection in Participants With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
Norroy Bioscience Co., LTD 600
Early research (Phase 1)Study completedNCT04666129
What this trial is testing

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Castration-Sensitive Prostate CancerNon-Metastatic Castration-Resistant Prostate Cancer
Sumitomo Pharma America, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07354594
What this trial is testing

External Beam and Radioligand Radiotherapy for mCRPC

Who this might be right for
Prostate Cancer Metastatic Castration-Resistant
Centre hospitalier de l'Université de Montréal (CHUM) 120
Early research (Phase 1)Study completedNCT05022849
What this trial is testing

JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 15
Not applicableUnknownNCT05116579
What this trial is testing

Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sun Yat-sen University 30
Not applicableStudy completedNCT04516161
What this trial is testing

EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Bayer 1,180
Not applicableStudy completedNCT01062503
What this trial is testing

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

Who this might be right for
Metastatic Prostate CancerBone Metastasis
University Health Network, Toronto 48
Testing effectiveness (Phase 2)Study completedNCT02598895
What this trial is testing

Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
University of Washington 14
Early research (Phase 1)Ended earlyNCT05084859
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

Who this might be right for
Castration-resistant Prostate CancerNon-small Cell Lung CancerColorectal Cancer
Biosplice Therapeutics, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01026623
What this trial is testing

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Study completedNCT05293496
What this trial is testing

MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCastration-Resistant Prostatic CancerMalignant Melanoma+4 more
MacroGenics 31
Testing effectiveness (Phase 2)Looking for participantsNCT07005154
What this trial is testing

Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate CancerMetastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 218
Testing effectiveness (Phase 2)Looking for participantsNCT04946370
What this trial is testing

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 52
Large-scale testing (Phase 3)Ended earlyNCT04876651
What this trial is testing

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Ltd 16
Not applicableStudy completedNCT03419442
What this trial is testing

Multi-academic Center Study of Xofigo Patients

Who this might be right for
Prostate Cancer, Castration Resistant
Bayer 150
Large-scale testing (Phase 3)Looking for participantsNCT07200830
What this trial is testing

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 1,524
Early research (Phase 1)Study completedNCT03751436
What this trial is testing

Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+6 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT00564928
What this trial is testing

Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmsCancer of the Prostate
Infinity Pharmaceuticals, Inc. 19
Next Page